Phreesia (PHR) | Stock Overview & Key Data
Phreesia Performance Comparison
Stock Range
Today's Range
Low: $26.53
High: $27.23
on August 8, 2025
52 Week Range
Low: $17.07
High: $30.53
on November 15, 2024
on February 14, 2025
All-Time High: $81.59 on February 8, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$1.4B
EPS
-1.02
P/E Ratio (TTM)
N/A
Forward P/E
-40.10
P/B Ratio
5.34
PEG Ratio
-40.10
Div. Yield
N/A
ROE
-22.67%
Beta
0.738
Debt to Equity
2.60
Financial Highlights
Profitability
Gross Margin
69.40%
Operating Margin
-46.68%
Profit Margin
-13.94%
Returns and Earnings
Return on Assets (TTM)
-8.75%
Return on Equity (TTM)
-22.67%
EBITDA
$-35.4M
Net Income (TTM)
$-58.5M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$7.15
Quarterly Revenue Growth (YoY)
45.70%
Quarterly Earnings Growth (YoY)
15.45%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Phreesia PHR | 1.43B Small-cap | 2.54% | -4.93% | 6.42% | -6.80% | 7.23% | 16.83% | 4.53% | -9.48% |
| Veeva Systems VEEV | 46.10B Large-cap | 0.28% | 0.53% | 17.78% | 18.64% | 33.98% | 50.99% | 25.19% | 9.21% |
| Ge Healthcare GEHC | 32.87B Large-cap | 3.08% | -4.26% | 2.13% | -17.71% | -8.14% | -13.67% | 26.89% | 26.89% |
| Premier PINC | 1.93B Small-cap | 9.69% | 6.43% | 0.13% | 25.63% | 9.17% | 16.77% | -39.29% | -37.03% |
| Certara CERT | 1.76B Small-cap | 14.68% | -4.04% | -7.83% | -21.86% | 2.63% | -12.55% | -37.70% | -71.27% |
| 10x Genomics TXG | 1.51B Small-cap | -6.04% | 0.33% | 42.41% | 1.91% | -13.39% | -39.84% | -74.52% | -88.03% |
Ownership & Short Interest
Insider Ownership
4.31%
Institutional Ownership
97.44%
Shares Short
2M
Short Ratio
4.77
Short % of Shares Outstanding
4.82%
Average 10-Day Volume
403K
Average 90-Day Volume
423K
Phreesia Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Phreesia would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is PHR's 52-week high and low?
- In the last 52 weeks, Phreesia reached a high of $30.53 (on February 14, 2025) and a low of $17.07 (on November 15, 2024).
- What is the market cap and P/E ratio for PHR?
- Curious about Phreesia's size and valuation? Its market capitalization stands at 1.43B. When it comes to valuation, the P/E ratio (trailing twelve months) is N/A, and the forward P/E (looking ahead) is -40.10.
- Does PHR pay dividends? If so, what's the yield?
- As for dividends, Phreesia isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Phreesia's main competitors or similar companies to consider before investing?
When looking at Phreesia, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Veeva Systems
VEEV46.10B Healthcare Health Information Services 50.99% 25.19% Ge Healthcare
GEHC32.87B Healthcare Health Information Services -13.67% 26.89% Premier
PINC1.93B Healthcare Health Information Services 16.77% -39.29% Certara
CERT1.76B Healthcare Health Information Services -12.55% -37.70% 10x Genomics
TXG1.51B Healthcare Health Information Services -39.84% -74.52% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Phreesia Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Phreesia's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -22.67%, the Debt to Equity ratio from the most recent quarter is 2.60, and its Gross Profit Margin stands at 69.40%.
- What is the recent revenue and earnings growth for PHR?
- Looking at Phreesia's growth, its revenue over the trailing twelve months (TTM) was $420M. Compared to the same quarter last year (YoY), quarterly revenue grew by 45.70%, and quarterly earnings saw a YoY growth of 15.45%.
- How much of PHR stock is held by insiders and institutions?
- Wondering who owns Phreesia stock? Company insiders (like executives and directors) hold about 4.31% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 97.44%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.